Analgesic & Anti-inflammatory Tablet Franchise in Ahmedabad

Naproxen 275mg Tablet Supplier in Mumbai

Pain Relief Tablet Distributor in Delhi

Musculoskeletal Therapy Tablet Manufacturer in Bangalore

Anti-inflammatory Tablet Stockist in Hyderabad
Naproxen Tablet Exporter in Chandigarh

Home/Products /naproxen-250mg-tablet

Naprohike 275 Tablet

Composition : Naproxen (275mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Naprohike 275 Tablet contains Naproxen 275mg, a non-steroidal anti-inflammatory drug (NSAID) widely used to relieve pain, inflammation, and stiffness associated with musculoskeletal disorders. It provides effective management for conditions such as arthritis, back pain, and post-operative pain.

Naproxen works by inhibiting cyclooxygenase (COX) enzymes, reducing the synthesis of prostaglandins, which are mediators of pain, inflammation, and fever. This mechanism ensures targeted relief of symptoms with proven clinical efficacy.

Clinically, Naprohike 275 Tablet is indicated for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, tendonitis, and dysmenorrhea. The tablet formulation ensures accurate dosing, good bioavailability, and convenient once- or twice-daily administration, improving patient compliance.

Regular use under medical supervision helps in reducing pain intensity, improving joint function, and enhancing mobility, contributing to better quality of life. Naprohike 275 Tablet is a trusted analgesic and anti-inflammatory therapy, offering reliable symptom control and safety.


Read More

About the Product

Naprohike 275 Tablet contains Naproxen 275mg, a non-steroidal anti-inflammatory drug (NSAID) widely used to relieve pain, inflammation, and stiffness associated with musculoskeletal disorders. It provides effective management for conditions such as arthritis, back pain, and post-operative pain.

Naproxen works by inhibiting cyclooxygenase (COX) enzymes, reducing the synthesis of prostaglandins, which are mediators of pain, inflammation, and fever. This mechanism ensures targeted relief of symptoms with proven clinical efficacy.

Clinically, Naprohike 275 Tablet is indicated for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, tendonitis, and dysmenorrhea. The tablet formulation ensures accurate dosing, good bioavailability, and convenient once- or twice-daily administration, improving patient compliance.

Regular use under medical supervision helps in reducing pain intensity, improving joint function, and enhancing mobility, contributing to better quality of life. Naprohike 275 Tablet is a trusted analgesic and anti-inflammatory therapy, offering reliable symptom control and safety.


Common side effects may include stomach upset, nausea, heartburn, or mild dizziness. Rarely, gastrointestinal bleeding, allergic reactions, kidney impairment, or cardiovascular complications may occur with prolonged use.

Naprohike 275 Tablet is indicated for the management of mild to moderate pain, inflammation, and swelling associated with conditions such as arthritis, musculoskeletal injuries, menstrual pain, and other inflammatory disorders, as advised by a physician.

For oral use only. Use strictly under medical supervision. Take with food or milk to reduce gastrointestinal discomfort. Inform your doctor if you have a history of stomach ulcers, kidney or liver disorders, or heart disease. Discontinue use and seek medical attention if severe reactions occur.

Store below 25°C in a cool, dry place. Protect from light and moisture. Keep the tablets tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation